-
srdr.ahrq.gov/projects/1604/studies/198036
January 01, 2004 - Key Questions Addressed
5
What is the effectiveness of drug, nondrug, and combination interventions
-
srdr.ahrq.gov/projects/1604/studies/198022
January 01, 2003 - Key Questions Addressed
5
What is the effectiveness of drug, nondrug, and combination interventions
-
srdr.ahrq.gov/projects/1604/studies/198041
January 01, 2010 - Key Questions Addressed
5
What is the effectiveness of drug, nondrug, and combination interventions
-
srdr.ahrq.gov/projects/1604/studies/198044
January 01, 2018 - Key Questions Addressed
5
What is the effectiveness of drug, nondrug, and combination interventions
-
srdr.ahrq.gov/projects/1604/studies/198033
January 01, 2011 - Key Questions Addressed
5
What is the effectiveness of drug, nondrug, and combination interventions
-
srdr.ahrq.gov/projects/1604/studies/198035
January 01, 2008 - Key Questions Addressed
5
What is the effectiveness of drug, nondrug, and combination interventions
-
srdr.ahrq.gov/projects/1604/studies/198024
January 01, 2017 - Key Questions Addressed
5
What is the effectiveness of drug, nondrug, and combination interventions
-
srdr.ahrq.gov/projects/1604/studies/198043
January 01, 2002 - Key Questions Addressed
5
What is the effectiveness of drug, nondrug, and combination interventions
-
srdr.ahrq.gov/projects/published
December 13, 2021 - Farchione, M.D., Deputy Director (Acting), Division of Psychiatry Products, Center for Drug Evaluation … Food and Drug Administration
DOI:
https://doi.org/10.23970/AHRQEPCCER224
Funding Source
-
srdr.ahrq.gov/projects/1604/studies/198039
January 01, 2010 - Key Questions Addressed
5
What is the effectiveness of drug, nondrug, and combination interventions
-
srdr.ahrq.gov/projects/1708
January 03, 2021 - ) patient education; (3) clinician and patient values and preferences related to opioids; (4) urine drug … screening; (5) use of prescription drug monitoring program data; (6) availability of close followup? … Hussain I, Hussain Shah SI, Amjad I.
2013
Clinical observation of a combination of acupuncture and drug … Zheng H., Mamdani MM., Juurlink DN., Bell CM.
2012
Association of the Use of a Mandatory Prescription Drug … Paluch E., Leyva R., DePadova E., Cruz-Rivera M., Kellstein D.
2020
Impact of a Mandatory Prescription Drug
-
srdr.ahrq.gov/projects/1542/studies/186834
January 01, 2011 - Many registers were used: Sweden Medical Birth Register, Swedish Prescribed Drug Register, Register of
-
srdr.ahrq.gov/projects/1520/studies/186803
January 01, 2017 - Select a Topic:
User Home Screen
Extraction Forms
Project Creation
Study Creation
Preview Pages
Other
Your Feedback:
Submit
Reset
Cancel
Study Preview
Study Title and Description
Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence. -A
Key Questio…
-
srdr.ahrq.gov/projects/1520/studies/186804
January 01, 2017 - Select a Topic:
User Home Screen
Extraction Forms
Project Creation
Study Creation
Preview Pages
Other
Your Feedback:
Submit
Reset
Cancel
Study Preview
Study Title and Description
Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence. -B
Key Questio…
-
srdr.ahrq.gov/projects/1520/studies/186807
January 01, 2013 - for at least 5 years before study enrolment were also acceptable), treatment with any investigational drug … the release of the active moiety from the tablets, recent history or suspicion of alcohol abuse or drug
-
srdr.ahrq.gov/projects/1565/studies/188960
January 01, 2016 - incompatible with wearing a CPAP facemask; history of head injury, psychiatric disorder including alcohol or drug
-
srdr.ahrq.gov/projects/1565/studies/189298
January 01, 2014 - Exclusion criteria
h/o psych disorder, h/o of trauma, alcohol/drug
-
srdr.ahrq.gov/projects/1565/studies/188328
January 01, 2016 - Note/Comment about baseline characteristics
drug use data available … drug use data available
Comments ( 0 ) |
Post/View
-
srdr.ahrq.gov/projects/592
April 01, 2015 - Lin, C.W.C.
2014
Drug Class Review: Long-Acting Opioid Analgesics: Final Update 6 Report
-
srdr.ahrq.gov/projects/1165
May 29, 2019 - Farchione, M.D., Deputy Director (Acting), Division of Psychiatry Products, Center for Drug Evaluation … Food and Drug Administration
Comments ( 0 ) |
Post/View
Methodology